Cargando…
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
• Discussion of the role of immunomodulatory agents to reduce the cytokine storm in severe cases of COVID-19. • Potential immunomodulatory agents currently used in the treatment of COVID-19 (chloroquine, hydroxychloroquine and tocilizumab) are discussed. • Other immunomodulatory agents with good saf...
Autor principal: | Zhao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161506/ https://www.ncbi.nlm.nih.gov/pubmed/32305588 http://dx.doi.org/10.1016/j.ijantimicag.2020.105982 |
Ejemplares similares
-
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020) -
The cytokine storm of severe influenza and development of immunomodulatory therapy
por: Liu, Qiang, et al.
Publicado: (2016) -
Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
por: Kovalchuk, Anna, et al.
Publicado: (2021) -
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm
por: Narain, Sonali, et al.
Publicado: (2021) -
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
por: Mohammed, Mona A.
Publicado: (2023)